Literature DB >> 18556625

Induction of angiogenesis by airway smooth muscle from patients with asthma.

David E Simcock1, Varsha Kanabar, Graham W Clarke, Katharina Mahn, Charlotta Karner, Brian J O'Connor, Tak H Lee, Stuart J Hirst.   

Abstract

RATIONALE: Airway remodeling in asthma involves accumulation of airway smooth muscle (ASM) and increased vascularity due to angiogenesis. Bronchial blood vessels and ASM are found in close proximity, and ASM releases multiple proinflammatory mediators, including vascular endothelial growth factor (VEGF).
OBJECTIVES: We examined whether release of proangiogenic mediators is increased in ASM from subjects with asthma and whether this is translated to induction of angiogenesis.
METHODS: Biopsy-derived ASM cells were cultured from 12 subjects with mild asthma, 8 with moderate asthma, and 9 healthy control subjects. Angiogenesis induced by cell-conditioned medium (CM) from ASM was evaluated in a tubule formation assay. Anti-CD31-labeled tubules were quantified by image analysis. Angiogenic factors in CM were quantified by antibody arrays and by enzyme-linked immunosorbent assay.
MEASUREMENTS AND MAIN RESULTS: Induction of angiogenesis by CM from unstimulated ASM was increased in subjects with mild asthma (twofold) and moderate asthma (threefold), compared with healthy CM (P < 0.001). Levels of angiogenic factors (VEGF, angiopoietin [Ang]-1, angiogenin) were similarly elevated in CM from subjects with asthma compared with that from healthy subjects (P < 0.05), whereas antiangiogenic factors (endostatin, Ang-2) were unchanged. VEGF, Ang-1, and angiogenin in combination increased vascularity (twofold, P < 0.01) in cultured intact biopsies. Selective VEGF immunodepletion abolished enhanced tubule formation by CM from asthmatic ASM (P < 0.01), but CM depletion of Ang-1 or angiogenin had no effect.
CONCLUSIONS: ASM cultured from subjects with mild or moderate asthma, but not from healthy control subjects, promotes angiogenesis in vitro. This proangiogenic capacity resides in elevated VEGF release and suggests that ASM regulates airway neovascularization in asthma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556625     DOI: 10.1164/rccm.200707-1046OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  25 in total

1.  Regulator of G-protein signaling-5 inhibits bronchial smooth muscle contraction in severe asthma.

Authors:  Zhao Yang; Nariman Balenga; Philip R Cooper; Gautam Damera; Richard Edwards; Christopher E Brightling; Reynold A Panettieri; Kirk M Druey
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

Review 2.  Mitochondrial regulation of airway smooth muscle functions in health and pulmonary diseases.

Authors:  Shi Pan; Stanley Conaway; Deepak A Deshpande
Journal:  Arch Biochem Biophys       Date:  2019-01-08       Impact factor: 4.013

3.  Counterpoint: alterations in airway smooth muscle phenotype do not cause airway hyperresponsiveness in asthma.

Authors:  Peter D Paré; Wayne Mitzner
Journal:  J Appl Physiol (1985)       Date:  2012-09-01

4.  Angiogenesis and airway reactivity in asthmatic Brown Norway rats.

Authors:  Elizabeth M Wagner; John Jenkins; Anne Schmieder; Lindsey Eldridge; Qiong Zhang; Aigul Moldobaeva; Huiying Zhang; John S Allen; Xiaoxia Yang; Wayne Mitzner; Jochen Keupp; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Angiogenesis       Date:  2014-08-23       Impact factor: 9.596

Review 5.  Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulation.

Authors:  Heng T Duong; Serpil C Erzurum; Kewal Asosingh
Journal:  Angiogenesis       Date:  2011-07-28       Impact factor: 9.596

Review 6.  Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways.

Authors:  Norbert Meyer; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

7.  Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily.

Authors:  Marianna Kulka; Nobuyuki Fukuishi; Dean D Metcalfe
Journal:  J Leukoc Biol       Date:  2009-07-22       Impact factor: 4.962

Review 8.  An imbalance in C/EBPs and increased mitochondrial activity in asthmatic airway smooth muscle cells: novel targets in asthma therapy?

Authors:  Michael Roth; Judith L Black
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

9.  Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma.

Authors:  Rachel L Clifford; Alison E John; Christopher E Brightling; Alan J Knox
Journal:  J Immunol       Date:  2012-06-11       Impact factor: 5.422

Review 10.  Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function.

Authors:  Rachel L Clifford; Cherie A Singer; Alison E John
Journal:  Pulm Pharmacol Ther       Date:  2012-07-16       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.